Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 7203758, 11 pages
https://doi.org/10.1155/2017/7203758
Research Article

Cellular Preoxygenation Partially Attenuates the Antitumoral Effect of Cisplatin despite Highly Protective Effects on Renal Epithelial Cells

1Razi Herbal Medicines Research Center and Department of Physiology, Lorestan University of Medical Sciences, Khorramabad, Iran
2Department of Physiology and Pharmacology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3Physiology-Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

Correspondence should be addressed to Ayat Kaeidi; ri.ca.smur@idieak.a

Received 17 November 2016; Accepted 15 January 2017; Published 19 February 2017

Academic Editor: Spencer Gibson

Copyright © 2017 Bahram Rasoulian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Hanigan and P. Devarajan, “Cisplatin nephrotoxicity: molecular mechanisms,” Cancer Therapy, vol. 1, pp. 47–61, 2003. View at Google Scholar
  2. R. P. Miller, R. K. Tadagavadi, G. Ramesh, and W. B. Reeves, “Mechanisms of cisplatin nephrotoxicity,” Toxins, vol. 2, no. 11, pp. 2490–2518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Lieberthal, V. Triaca, and J. Levine, “Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis,” American Journal of Physiology, vol. 270, no. 4, pp. F700–F708, 1996. View at Google Scholar · View at Scopus
  4. K. B. Meyer and N. E. Madias, “Cisplatin nephrotoxicity,” Mineral and Electrolyte Metabolism, vol. 20, no. 4, pp. 201–213, 1994. View at Google Scholar
  5. A. Kaeidi, B. Rasoulian, Z. Hajializadeh, S. Pourkhodadad, and M. Rezaei, “Cisplatin toxicity reduced in human cultured renal tubular cells by oxygen pretreatment,” Renal Failure, vol. 35, no. 10, pp. 1382–1386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Rasoulian, M. Jafari, M. Mahbod et al., “Pretreatment with oxygen protects rat kidney from cisplatin nephrotoxicity,” Renal Failure, vol. 32, no. 2, pp. 234–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Rasoulian, A. Kaeidi, S. Pourkhodadad et al., “Effects of pretreatment with single-dose or intermittent oxygen on cisplatin-induced nephrotoxicity in rats,” Nephro-Urology Monthly, vol. 6, no. 5, Article ID e19680, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Saadat, S. S. Shariat Maghani, Z. Rostami et al., “Normobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity,” Renal Failure, vol. 36, no. 1, pp. 5–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Selvendiran, M. L. Kuppusamy, S. Ahmed et al., “Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions,” Cancer Biology and Therapy, vol. 10, no. 4, pp. 386–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Alagoz, R. E. Buller, B. Anderson et al., “Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice,” Cancer, vol. 75, no. 9, pp. 2313–2322, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Desoize and C. Madoulet, “Particular aspects of platinum compounds used at present in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 317–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Shah and D. S. Dizon, “New-generation platinum agents for solid tumors,” Future Oncology, vol. 5, no. 1, pp. 33–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Mukherjea, S. Jajoo, T. Kaur, K. E. Sheehan, V. Ramkumar, and L. P. Rybak, “Transtympanic administration of short interfering (si)rna for the nox3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat,” Antioxidants and Redox Signaling, vol. 13, no. 5, pp. 589–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Çetin, E. Devrim, B. Kiliçoğlu, A. Avci, Ö. Çandir, and I. Durak, “Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods,” Journal of Applied Toxicology, vol. 26, no. 1, pp. 42–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. K. A. Bauer, M. Vogt, M. Los, J. Siegel, S. Wesselborg, and K. Schulze-Osthoff, “Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression,” The Journal of Biological Chemistry, vol. 273, no. 14, pp. 8048–8055, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kruidering, B. Van De Water, E. De Heer, G. J. Mulder, and J. F. Nagelkerke, “Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain,” Journal of Pharmacology and Experimental Therapeutics, vol. 280, no. 2, pp. 638–649, 1997. View at Google Scholar · View at Scopus
  17. G. Nowak, “Protein kinase C-α and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells,” The Journal of Biological Chemistry, vol. 277, no. 45, pp. 43377–43388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Bigdeli, S. Hajizadeh, M. Froozandeh et al., “Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-α level,” Experimental Neurology, vol. 212, no. 2, pp. 298–306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. R. Bigdeli, S. Hajizadeh, M. Froozandeh, B. Rasulian, A. Heidarianpour, and A. Khoshbaten, “Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue,” Brain Research, vol. 1152, no. 1, pp. 228–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Dong, L. Xiong, Z. Zhu, S. Chen, L. Hou, and T. Sakabe, “Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits,” Anesthesiology, vol. 96, no. 4, pp. 907–912, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Nie, L. Xiong, N. Lao, S. Chen, N. Xu, and Z. Zhu, “Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 5, pp. 666–674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-Y. Yu, J.-H. Chiu, S.-D. Yang et al., “Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats,” Journal of Surgical Research, vol. 128, no. 1, pp. 28–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Liu, X.-J. Sun, J. Liu, Z.-M. Kang, and X.-M. Deng, “Heme oxygenase-1 could mediate the protective effects of hyperbaric oxygen preconditioning against hepatic ischemia-reperfusion injury in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 10, pp. 675–682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Foadoddini, M. Esmailidehaj, H. Mehrani et al., “Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection,” European Journal of Cardio-thoracic Surgery, vol. 39, no. 2, pp. 233–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Rasoulian, H. Mohammadhosseniakbari, M. Kadkhodaee et al., “Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury,” Journal of Surgical Research, vol. 146, no. 2, pp. 282–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Wahhabaghai, B. Rasoulian, M. Esmaili et al., “Hyperoxia-induced protection against rat's renal ischemic damage: relation to oxygen exposure time,” Renal Failure, vol. 31, no. 6, pp. 514–521, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Saini, R. J. Gumina, B. Wolfe, M. L. Kuppusamy, P. Kuppusamy, and K. D. Boudoulas, “Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation,” Journal of Cellular Biochemistry, vol. 114, no. 11, pp. 2612–2623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Einollahi, F. Poor-Reza-Gholi, S. Rezaeean et al., “Deceased-donor hyperoxia deteriorates kidney graft function,” Transplant International, vol. 24, no. 2, pp. e16–e18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Montazeri, M. Vakily, A. Honarmand et al., “Short-time intermittent preexposure of living human donors to hyperoxia improves renal function in early posttransplant period: a double-blind randomized clinical trial,” Journal of Transplantation, vol. 2011, Article ID 204843, 8 pages, 2011. View at Publisher · View at Google Scholar
  30. Z. Rostami, B. Einollahi, and M. H. Ghadiani, “Does living donor hyperoxia have an impact on kidney graft function after transplantation,” Nephro-Urology Monthly, vol. 5, no. 3, pp. 835–839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Tähepôld, G. Valen, J. Starkopf, C. Kairane, M. Zilmer, and J. Vaage, “Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart,” Life Sciences, vol. 68, no. 14, pp. 1629–1640, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Bigdeli, B. Rasoulian, and A. A. Meratan, “In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue,” European Journal of Pharmacology, vol. 611, no. 1–3, pp. 22–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Baharvand, M. E. Dehaj, M. Foadaddini et al., “Delayed cardioprotective effects of hyperoxia preconditioning prolonged by intermittent exposure,” Journal of Surgical Research, vol. 160, no. 1, pp. 53–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Tinits, “Oxygen therapy and oxygen toxicity,” Annals of Emergency Medicine, vol. 12, no. 5, pp. 321–328, 1983. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Pabla and Z. Dong, “Cisplatin nephrotoxicity: mechanisms and renoprotective strategies,” Kidney International, vol. 73, no. 9, pp. 994–1007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Arany and R. L. Safirstein, “Cisplatin nephrotoxicity,” Seminars in Nephrology, vol. 23, no. 5, pp. 460–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Gabb and E. D. Robin, “Hyperbaric oxygen: a therapy in search of diseases,” Chest, vol. 92, no. 6, pp. 1074–1082, 1987. View at Publisher · View at Google Scholar · View at Scopus
  38. P. M. Tibbles and J. S. Edelsberg, “Hyperbaric-oxygen therapy,” The New England Journal of Medicine, vol. 334, no. 25, pp. 1642–1648, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Bennett, J. Feldmeier, N. Hampson, R. Smee, and C. Milross, “Hyperbaric oxygen therapy for late radiation tissue injury,” Cochrane Database of Systematic Reviews, vol. 5, Article ID CD005005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. Feldmeier, “Hyperbaric oxygen for delayed radiation injuries,” Undersea and Hyperbaric Medicine, vol. 31, no. 1, pp. 133–145, 2004. View at Google Scholar · View at Scopus
  41. D. Mathieu, Handbook on Hyperbaric Medicine, Springer, Berlin, Germany, 2006. View at Publisher · View at Google Scholar
  42. E. V. Granowitz, N. Tonomura, R. M. Benson et al., “Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation,” Anticancer Research, vol. 25, no. 6, pp. 3833–3842, 2005. View at Google Scholar · View at Scopus
  43. T. B. Sun, R. L. Chen, and Y. H. Hsu, “The effect of hyperbaric oxygen on human oral cancer cells,” Undersea and Hyperbaric Medicine, vol. 31, no. 2, pp. 251–260, 2004. View at Google Scholar · View at Scopus
  44. Y.-C. Chen, S.-Y. Chen, P.-S. Ho et al., “Apoptosis of T-leukemia and B-myeloma cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPK,” Leukemia Research, vol. 31, no. 6, pp. 805–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Kawasoe, M. Yokouchi, Y. Ueno, H. Iwaya, H. Yoshida, and S. Komiya, “Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma,” Oncology Reports, vol. 22, no. 5, pp. 1045–1050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Raa, C. Stansberg, V. M. Steen, R. Bjerkvig, R. K. Reed, and L. E. B. Stuhr, “Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors,” BMC Cancer, vol. 7, article 23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. L. E. B. Stuhr, A. Raa, A. M. Øyan et al., “Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats,” Journal of Neuro-Oncology, vol. 85, no. 2, pp. 191–202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Moen, A. M. Øyan, K.-H. Kalland et al., “Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model,” PLoS ONE, vol. 4, no. 7, Article ID e6381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. A. Godman, R. Joshi, C. Giardina, G. Perdrizet, and L. E. Hightower, “Hyperbaric oxygen treatment induces antioxidant gene expression,” Annals of the New York Academy of Sciences, vol. 1197, pp. 178–183, 2010. View at Publisher · View at Google Scholar · View at Scopus